Business Insider North Carolina
SEE OTHER BRANDS

Your business and economy news from North Carolina

Governor Stein Spotlights North Carolina’s Leadership in Biotech Industry at Fujifilm Biotechnologies Ribbon-Cutting Ceremony

NORTH CAROLINA, September 24 - Today Governor Josh Stein joined leaders of Fujifilm Biotechnologies and local officials at the ribbon-cutting ceremony for the company’s new facility in Holly Springs, highlighting North Carolina’s leadership in the biotech industry. 

“North Carolina is home to the future of biotech, and we welcome Fujifilm an industry leader,” said Governor Josh Stein. “This overall project will create 1,400 new, good-paying jobs in North Carolina by 2031 and will grow our state’s economy by more than $10 billion over the next decade. Fujifilm isn’t just strengthening the workforce of today – it’s investing in the workforce of tomorrow.”

Fujifilm Biotechnologies’ new Holly Springs facility is home to bioreactors that will aid in the large-scale manufacturing of antibodies and vaccines. Fujifilm has also partnered with Wake Tech to establish a biomechatronics apprenticeship program. Governor Stein’s Advisory Council on Workforce and Apprenticeships, which published its first report in June, seeks to expand access to good jobs with good wages by investing in apprenticeship and technical education programs and securing a post-secondary path for every student in North Carolina.

North Carolina is home to a growing life sciences sector, which employs more than 225,000 people and generates $88.3 billion in annual economic activity. Since taking office in January, Governor Stein has announced more than $19 billion in new investments and more than 26,000 new, good-paying jobs coming to North Carolina. Last week, at the NC Biotech 40th Anniversary Summit, Governor Stein proclaimed September 15-19 as Life Sciences Week and highlighted the state’s leadership in the field.  

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions